AAS
GRCE

Avantax Advisory Services’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Avantax Advisory Services’s Portfolio GRCE Stock Details GRCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-349
Closed -$3K – 1377
2020
Q3 		$3K Buy
+349
New +$3K ﹤0.01% 1375